REFERENCES - RESEARCH FRONT: 4
| Times Cited | Reference | Title |
| 12 |
PERETZ D, 2001, NATURE, V412, P739 |
null |
| 12 |
BUELER H, 1993, CELL, V73, P1339 |
null |
| 12 |
ENARI M, 2001, P NATL ACAD SCI USA, V98, P9295 |
Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody |
| 11 |
HEPPNER FL, 2001, SCIENCE, V294, P178 |
Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies |
| 11 |
KLEIN MA, 1997, NATURE, V390, P687 |
null |
| 9 |
BUELER H, 1992, NATURE, V356, P577 |
null |
| 9 |
MONTRASIO F, 2000, SCIENCE, V288, P1257 |
null |
| 9 |
BRANDNER S, 1996, NATURE, V379, P339 |
Normal host prion protein necessary for scrapie-induced neurotoxicity |
| 9 |
KLEIN MA, 1998, NAT MED, V4, P1429 |
null |
| 7 |
BRUCE ME, 1997, NATURE, V389, P498 |
null |
| 7 |
SOTO C, 2000, LANCET, V355, P192 |
Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides |
| 7 |
GLATZEL M, 2001, NEURON, V31, P25 |
null |
| 7 |
KLEIN MA, 2001, NAT MED, V7, P488 |
null |
| 7 |
KITAMOTO T, 1991, J VIROL, V65, P6292 |
null |
| 6 |
WHITE AR, 2003, NATURE, V422, P80 |
Monoclonal antibodies inhibit prion replication and delay the development of prion disease |
| 6 |
FISCHER M, 1996, EMBO J, V15, P1255 |
null |
| 6 |
BLATTLER T, 1997, NATURE, V389, P69 |
null |
| 6 |
AUCOUTURIER P, 2001, J CLIN INVEST, V108, P703 |
null |
| 6 |
KORTH C, 1997, NATURE, V390, P74 |
null |
| 5 |
HOUSTON F, 2000, LANCET, V356, P999 |
null |
| 5 |
TELLING GC, 1995, CELL, V83, P79 |
PRION PROPAGATION IN MICE EXPRESSING HUMAN AND CHIMERIC PRP TRANSGENES IMPLICATES THE INTERACTION OF CELLULAR PRP WITH ANOTHER PROTEIN |
| 5 |
SETHI S, 2002, LANCET, V360, P229 |
Postexposure prophylaxis against prion disease with a stimulator of innate immunity |
| 5 |
GLATZEL M, 2003, NEW ENGL J MED, V349, P1812 |
null |
| 5 |
SIGURDSSON EM, 2002, AM J PATHOL, V161, P13 |
Immunization delays the onset of prion disease in mice |
| 5 |
SOUAN L, 2001, EUR J IMMUNOL, V31, P2338 |
null |
| 5 |
CAUGHEY B, 1992, J NEUROCHEM, V59, P768 |
null |
| 5 |
MABBOTT NA, 2000, NAT MED, V6, P719 |
null |
| 5 |
AGUZZI A, 2001, NAT REV MOL CELL BIO, V2, P118 |
null |
| 5 |
PRUSINER SB, 1982, SCIENCE, V216, P136 |
null |
| 5 |
BROWN KL, 1999, NAT MED, V5, P1308 |
null |
| 4 |
SIGURDSSON EM, 2003, NEUROSCI LETT, V336, P185 |
Anti-prion antibodies for prophylaxis following prion exposure in mice |
| 4 |
TAGLIAVINI F, 1997, SCIENCE, V276, P1119 |
Effectiveness of anthracycline against experimental prion disease in Syrian hamsters |
| 4 |
AGUZZI A, 1997, NATURE, V389, P795 |
null |
| 4 |
SUPATTAPONE S, 2001, J VIROL, V75, P3453 |
null |
| 4 |
PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608 |
null |